Related Experiment Video
Updated: Apr 6, 2026
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diabetic Cardiomyopathy; Summary of 41 Years
Samet Yilmaz1, Ugur Canpolat1, Sinan Aydogdu1
1Turkey Yuksek Ihtisas Education and Research Hospital, Cardiology Clinic, Ankara, Turkey.
Insights
Diabetic cardiomyopathy, a heart condition in diabetes patients, arises from hyperglycemia-induced protein damage and oxidative stress. Early diagnosis and traditional heart failure treatments are key, but specific diabetic cardiac strategies require further research.
Area of Science:
- Cardiology
- Endocrinology
- Pathophysiology
Background:
- Diabetic cardiomyopathy (DCM) is an independent risk factor for heart failure in diabetic patients.
- It occurs even without traditional risk factors like hypertension and coronary artery disease.
- Pathophysiological mechanisms include hyperglycemia-induced protein glycosylation, oxidative stress, and fibrosis.
Purpose of the Study:
- To review the pathophysiology of diabetic cardiomyopathy.
- To summarize current diagnostic approaches.
- To discuss therapeutic strategies for diabetic cardiac dysfunction.
Main Methods:
- Review of clinical and experimental studies.
- Analysis of pathophysiological mechanisms.
- Summary of diagnostic techniques and therapeutic interventions.
Main Results:
- Hyperglycemia leads to impaired cardiac function through non-enzymatic glycosylation, reactive oxygen species, fibrosis, impaired calcium handling, and increased fatty acid oxidation.
- Sensitive diagnostic techniques can detect left ventricular hypertrophy and diastolic/systolic dysfunction.
- Traditional heart failure treatments show benefit, but specific preventative and therapeutic strategies for DCM remain unclear.
Conclusions:
- Diabetic cardiomyopathy is a significant complication of diabetes mellitus.
- Understanding its pathophysiology is crucial for diagnosis and management.
- Further research is needed to clarify specific treatment strategies for diabetic cardiac dysfunction.
Abstract:
Patients with diabetes have an increased risk for development of cardiomyopathy, even in the absence of well known risk factors like coronary artery disease and hypertension. Diabetic cardiomyopathy was first recognized approximately four decades ago. To date, several pathophysiological mechanisms thought to be responsible for this new entity have also been recognized. In the presence of hyperglycemia, non-enzymatic glycosylation of several proteins, reactive oxygen species formation, and fibrosis lead to impairment of cardiac contractile functions. Impaired calcium handling, increased fatty acid oxidation, and increased neurohormonal activation also contribute to this process. Demonstration of left ventricular hypertrophy, early diastolic and late systolic dysfunction by sensitive techniques, help us to diagnose diabetic cardiomyopathy. Traditional treatment of heart failure is beneficial in diabetic cardiomyopathy, but specific strategies for prevention or treatment of cardiac dysfunction in diabetic patients has not been clarified yet. In this review we will discuss clinical and experimental studies focused on pathophysiology of diabetic cardiomyopathy, and summarize diagnostic and therapeutic approaches developed towards this entity.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:25Cardiomyopathy I: Introduction and Classification
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:29Cardiomyopathy V: Interprofessional Care
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
01:21Myocarditis I: Introduction